Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.

Thomas K Jones,Doff B McElhinney,Julie A Vincent,William E Hellenbrand,John P Cheatham,Darren P Berman,Evan M Zahn,Danyal M Khan,John F Rhodes,Shicheng Weng,Lisa J Bergersen

Circulation. Cardiovascular interventions（2022）

引用 14|浏览5

暂无评分

摘要

Ten-year outcomes from the Melody Investigational Device Exemption trial affirm the benefits of Melody TPV replacement in the lifetime management of patients with RVOT conduits and bioprosthetic pulmonary valves by providing sustained symptomatic and hemodynamic improvement in the majority of patients. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00740870.

查看译文

关键词

endocarditis,heart diseases,humans,mortality,pulmonary valve

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要